Navigation Links
Proove Health Foundation Is Created to Support the Role of Personalized Medicine in Public Health Epidemics
Date:4/29/2016

Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, is excited to announce the launch of the Proove Health Foundation. The Foundation is a non-profit organization dedicated to supporting public health studies, volunteerism, and education to promote the use of personalized medicine for tackling the nation’s most-pressing healthcare epidemics. As part of this effort, the Foundation sponsors public health research studies, educational programs, and volunteer activities. “By investing in research, education, and activism, we are able to invest in a better future,” said Catherine Meshkin, Esq., Founder of the Proove Health Foundation.

According to the American Academy of Orthopedic Surgeons, musculoskeletal disease is a nationwide epidemic—and it is the leading cause of physical disability in the United States of America. With more than 55 million Americans suffering from low-back pain, chronic pain is the most prevalent and expensive health condition in country—more than cancer, diabetes, and heart disease combined. According to the Centers for Disease Control & Prevention, physicians wrote nearly 259 million prescriptions for opioids in 2012 as a cost-effective and clinically-effective approach for controlling the epidemic of unresolved pain. With the rise in opioid prescriptions, however, three of four prescription overdoses are now due to opioids—and opioid abuse is a national epidemic that has become the leading cause of injury death.

To help find solutions to these related epidemics, the Foundation is sponsoring the Evaluation of Population-Based Incidences of Drug Abuse, Prescription Ethical Medication Irregularities, and Compliance Behaviors (EPIDEMIC) study. The EPIDEMIC study is aimed at collecting information to evaluate socioeconomic factors and other issues that contributed to abuse in order to create guidelines that help promote pain control and reduce opioid abuse. “With the EPIDEMIC study, we are confident that sufficient data will be gathered to support the creation of evidence-based guidelines that truly change lives,” said Meshkin.

The Foundation further provides information related to public health and community-based initiatives. The goal is to serve as a resource for the public while creating strong ties within the community. As a result, local residents are able to volunteer through the Foundation, participate in internships and mentoring programs, and gain access to unique educational opportunities. As part of this focus, the Foundation partnered with Families Forward to prepare food bags for local families in need while working with the Friendly Center in Orange to distribute Easter Baskets to children. In addition, volunteers supported runners at the Los Angeles Marathon in February, 2016.

As an effort to engage and educate the community, the Foundation is creating an innovative Museum of Personalized Medicine. Scheduled to open in Summer of 2017, the Foundation is expected to bring a better understanding of the link between genetics and health to local residents. “Patterned after the founding of the Computer History Museum in Mountain View, California, the Foundation hopes to create a museum that inspires a future generation of innovators,” said Meshkin.

About Proove Biosciences Our mission is to change the future of medicine. Proove represents the proof to improve healthcare decisions. We seek to realize a future when clinicians look back and wonder how they could have ever prescribed medications without knowing how a patient would respond. Physicians use Proove Biosciences testing to improve outcomes—both safety and efficacy of medical treatment. From a simple cheek swab collected in the office, Proove performs proprietary genetic tests in its CLIA-certified laboratory to identify patients at risk for misuse of prescription pain medications and evaluate their metabolism of medications. For more information, please visit http://www.proove.com or call toll free 855-PROOVE-BIO (855-776-6832).

Read the full story at http://www.prweb.com/releases/2016/05/prweb13381896.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. Proove Biosciences Will Participate at the California Society of Interventional Pain Physician’s 4th Annual Meeting This Weekend
2. Proove CEO and Vice Chairman of the Howard County Board of Education, Brian Meshkin, Selected as one of Howard County's Finest Under 39 by the Cystic Fibrosis Foundation
3. Proove Biosciences Continues Its Research Leadership in the Genetics of Pain Medicine at The American Academy of Pain Management’s 24th Annual Meeting
4. Proove Biosciences Announces Sponsorship of National Drug Take Back Day and HC DrugFree
5. Proove Biosciences Will Be Exhibiting At The 2013 Common Sense Pain Management Conference
6. Proove Biosciences to Present Research on the Genetics of Pain Medicine and Exhibit at ASRA’s 12th Annual Pain Medicine Meeting
7. Proove Biosciences Will Be Exhibiting at the National Workers Compensation Conference and Expo on November 20-22
8. Proove Biosciences CEO Brian Meshkin Wins 2013 Bridging the Gap Award by the Greater Baltimore Committee
9. Proove Biosciences Successfully Presents Data and Exhibits at the Eastern Pain Association’s Annual Meeting in New York, New York
10. Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting
11. Proove Biosciences Exhibits Industry Leading Data and Research at PAINWeek 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive ... a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces a presentation by Subbu ... , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving Tree ... products targeting the needs of consumers who are incorporating medical marijuana into their ... Phoenix, Arizona. , As operators of two successful Valley dispensaries, The Giving Tree’s ...
Breaking Biology Technology:
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, 2017, ... the Genome hackathon at Microsoft,s headquarters in ... competition will focus on developing health and wellness apps ... Hack the Genome is the first hackathon ... The world,s largest companies in the genomics, tech and ...
(Date:3/27/2017)... March 27, 2017  Catholic Health Services (CHS) ... Systems Society (HIMSS) Analytics for achieving Stage 6 ... sm . In addition, CHS previously earned a ... using an electronic medical record (EMR). ... level of EMR usage in an outpatient setting.  ...
Breaking Biology News(10 mins):